Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1985-01-16
1986-05-13
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
514167, 514169, 514170, A61K 31595, A61K 3159, A61K 3156
Patent
active
045887160
ABSTRACT:
A method for treating or preventing metabolic bone disease characterized by loss of bone mass in mammals by administering 24-epi-1.alpha.,25-dihydroxy vitamin D.sub.2 alone or in combinations thereof with bone mobilization-inducing vitamin D derivatives to said mammals.
REFERENCES:
patent: 3697559 (1972-10-01), DeLuca et al.
patent: 3741996 (1973-06-01), DeLuca et al.
patent: 4159326 (1979-06-01), Barton et al.
patent: 4225596 (1980-09-01), DeLuca
patent: 4448721 (1984-05-01), DeLuca et al.
DeLuca Hector F.
Schnoes Heinrich K.
Bremer Howard W.
Robinson Douglas W.
Wisconsin Alumni Research Foundation
LandOfFree
Method for treating metabolic bone disease in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating metabolic bone disease in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating metabolic bone disease in mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1770217